Cell Therapy Human Raw Materials Global Market Growth Opportunities, Emerging Trends, Industry Analysis And Global Forecast 2024 To 2033
Global cell therapy human raw materials market size is expected to reach $5.86 Bn by 2028 at a rate of 20.2%, segmented as by product, cell culture media, cell culture sera, cell culture supplements
santhosh kumar Share this Post to earn Money ( Upto ₹100 per 1000 Views )
Cell therapy human raw materials are biological substances derived from human sources, such as cells, tissues, and blood components, used as foundational elements in the development and manufacturing of cell-based therapeutic products. These raw materials are employed in various stages of cell therapy production to create treatments for diseases such as cancer, genetic disorders, and degenerative conditions.
Sizing and Forecast
The cell therapy human raw materials market size has grown exponentially in recent years. It will grow from $2.34 billion in 2023 to $2.81 billion in 2024 at a compound annual growth rate (CAGR) of 20.1%. The growth in the historic period can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, high demand for regenerative medicines, governmental funding and support, and growing healthcare expenditure.
The cell therapy human raw materials market size is expected to see exponential growth in the next few years. It will grow to $5.86 billion in 2028 at a compound annual growth rate (CAGR) of 20.2%. The growth in the forecast period can be attributed to expanding therapeutic applications, rising patient awareness, favorable regulatory frameworks, a growing biopharmaceutical sector, and improved manufacturing processes. Major trends in the forecast period include the adoption of allogeneic therapies, the integration of artificial intelligence, an increase in off-the-shelf cell therapies, the use of 3D bioprinting technology, and the and the development of hybrid cell therapies.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/cell-therapy-human-raw-materials-global-market-report
Segmentation & Regional Insights
The cell therapy human raw materials market covered in this report is segmented –
1) By Product: Cell Culture Media, Cell Culture Sera, Cell Culture Supplements, Reagents And Buffers, Other Raw Materials
2) By Type Of Cell Therapy: Dendritic Cell Therapy, Natural Killer (NK) Cell Therapy, Stem Cell Therapy, T-Cell Therapy
3) By End-Use: Biopharmaceutical And Pharmaceutical Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organization (CMOs), Academic And Research Institutions
North America was the largest region in the cell therapy human raw materials market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy human raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15759&type=smp
Major Driver Impacting Market Growth
The rising adoption of regenerative medicine is expected to drive the cell therapy human raw materials market going forward. Regenerative medicine involves harnessing the body's own regenerative capabilities or using external stimuli such as stem cells, tissue engineering, or gene therapy to repair, replace, or regenerate damaged tissues and organs, aiming to restore normal function. Regenerative medicine gains visibility due to advancements in biotechnology, a rise in understanding cellular mechanisms, a growing demand for personalized medicine, and the potential to address unmet medical needs more effectively. Cell therapy and human raw materials facilitate the rising adoption of regenerative medicine by providing the essential biological components necessary for cell-based therapies, enabling the production of standardized and reliable treatments for various medical conditions. For instance, in August 2023, according to a report by the Alliance for Regenerative Medicine, a US-based non-profit organization, there were 2760 cell, gene, and tissue-engineering therapeutic developers worldwide in Q1 2023, up 101% since 1369 in Q1 2022. Moreover, financing for regenerative medicine and advanced therapies in 2021 will reach $22.7 billion, compared to $19.9 billion in 2020. Therefore, the rising adoption of regenerative medicine is driving the cell therapy human raw materials market.
Key Industry Players
Major companies operating in the cell therapy human raw materials market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE Healthcare, Corning Incorporated, Lonza Group Ltd., Grifols S.A., WuXi AppTec, Catalent Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Pall Corporation, Bio-Techne Corporation, Miltenyi Biotec, Actylis, STEMCELL Technologies, Takara Bio Inc., Vericel Corporation, ACROBiosystems, BioIVT LLC, Orgenesis Inc., PromoCell GMBH, ViaCyte Inc., AllCells LLC, Sartorius CellGenix GmbH, Fujifilm Cellular Dynamics Inc., Mesoblast Limited, RoosterBio Inc., Thermogenesis Holdings Inc.
The cell therapy human raw materials market report table of contents includes:
1. Executive Summary
2. Cell Therapy Human Raw Materials Market Report Structure
3. Cell Therapy Human Raw Materials Market Trends And Strategies
4. Cell Therapy Human Raw Materials Market – Macro Economic Scenario
5. Cell Therapy Human Raw Materials Market Size And Growth
…..
27. Cell Therapy Human Raw Materials Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the trending research reports from TBRC:
https://topprnews.com/gluten-feed-market
https://topprnews.com/organic-feed-market
https://topprnews.com/organic-pigments-market
https://goodprnews.com/rapeseed-oil-market
https://goodprnews.com/gluten-feed-market
https://goodprnews.com/manufactured-soil-market
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info
Healthcare Blog: https://healthcareresearchreports.com
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
